ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2021

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.

D J McGrail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.